We are excited to announce the acquisition of Assay.Works by Partex N.V., a Digital Pharma platform contributing to the biopharma value chain, from Data to Drugs. Partex is registered in Amsterdam, The Netherlands, and headquartered in Eschborn, Germany.
Joining forces with Partex will allow us to build a stable, long-term perspective by expanding our market reach, leveraging synergies, and continuing to invest in our capabilities.
Business will continue as usual. Assay.Works GmbH will operate as a separate legal entity and our management and scientific team will continue working with you in their current roles.
